Key Takeaways
- Indie beauty brands focused on science and innovation are poised for acquisition, according to Kline & Company.
- Notable potential acquisition targets include Ourself, Crown Affair, and 111Skin, all emphasizing clinical credibility.
- Despite a decline in beauty deal volume, industry experts expect selective acquisition activity to resume, especially for differentiated brands.
Science Drives Beauty Industry Acquisitions
A recent report by Kline & Company reveals that the beauty industry is pivoting towards science rather than sex appeal as its primary selling point. The analysis identifies 20 indie beauty brands likely to be targeted for acquisition, with a significant emphasis on those grounded in scientific principles and professional expertise.
Among the candidates, brands like Ourself, a biotechnology-driven skincare line, and 111Skin, founded by a plastic surgeon, have garnered attention as top contenders. Crown Affair, a haircare brand, follows closely, along with makeup brands Tower 28 and Salt & Stone. Other brands highlighted in this report include Angela Caglia, Augustinus Bader, Plated, Dr. Diamond’s Metacine, Hydrinity, and Nutrire.
Kline’s analysis notes that the brands featured possess strong market positioning, innovative product pipelines, and a mix of both online and offline distribution strategies, allowing them to scale effectively. An example of this foresight is the recent acquisition of Colorscience by RoundTable Healthcare Partners, which underscores the ongoing interest in high-growth beauty assets.
While beauty deal volume fell by 6.7% over the first nine months of last year, notable acquisitions such as E.l.f. Beauty’s purchase of Rhode and L’Oréal’s acquisitions of Color Wow and Medik8 indicate a continued appetite for strategic investments. As the market stabilizes, experts predict an uptick in selective acquisitions, especially for profitable brands demonstrating technological innovation and clinical credibility.
In the current deal environment, brands that are distinct and show strong profitability are expected to command premium valuations. The report highlights five brands deemed most likely to transact, all showcasing different approaches to blending science with beauty:
-
Ourself: Founded in 2022, this skincare brand links luxury cosmetics with dermatological advancements. Its bestselling product, the Advanced Regenerative Serum, has garnered significant praise.
- Funding: $70.3 million
-
Crown Affair: This 2020 haircare brand combines clean formulas with luxurious tools, appealing particularly to high-end consumers with a minimalist ethos.
- Funding: $23.1 million
-
111Skin: Known for its post-procedure skincare catered to the luxury market, this brand was launched in 2012 and also enjoys strong consumer trust.
- Funding: $15.7 million
-
Tower 28: A clean makeup brand founded in 2019, it focuses on affordable products designed for sensitive skin, making it a rising star in the cosmetics industry.
- Funding: $29.2 million
-
Salt & Stone: Established in 2017, this body care brand blends premium, clean products with functional performance, targeting wellness-focused consumers.
- Funding: $54 million
The report also highlights additional brands across categories like skincare, makeup, haircare, fragrance, and body care. Companies such as Angela Caglia and Augustinus Bader are recognized for their innovative approaches to skincare, while brands like Octavia Morgan and Vacation offer unique takes in fragrance and sun care.
As the beauty industry continues to evolve, the emphasis on scientific integrity and innovation appears to be shaping the landscape of potential acquisitions. Investors are expected to focus on brands that not only deliver quality products but also embody a sense of professional authority and technological advancement. The report concludes with the optimistic outlook for future deal-making, driven by the industry’s durable growth potential.
The content above is a summary. For more details, see the source article.
